Care in the prevention of the vertical tansmission of hepatitis B virus
DOI:
https://doi.org/10.60108/ce.91Keywords:
hepatitis b; pregnant; care; treatment; nursingAbstract
Summary. The Hepatitis B Virus (HBV) is a virus with a very high probability of causing liver cancer. At present, there is no curative treatment, so the main thing is to avoid infection, with vertical transmission being the most frequent. Therefore, it is necessary to take certain preventive measures in pregnancy, to prevent the woman with the virus from infecting the fetus.
Objective. To know the different measures of prevention of the transmission of HBV in pregnancy.
Methodology. A bibliographic search is carried out in international and Hispanic American databases, in which 1,215 articles are initially obtained, which after applying a filter of years and selecting those that fit the theme, turn out to be 23 used.
Conclusion. In pregnant women with hepatitis B special care is needed, since it is fundamentally to prevent infection in the fetus. For this, according to the state of the mother's illness, the situation is handled in different ways.
References
Toro- Rendón LG. Infección por el virus de la Hepatitis B en el embarazo. Med UIS. 2018; 31 (2): 49-56.
Zhou C, Yu Y, Yang Q, Wang H, Hou M, Jin L, et al. Motor development delay in offspring is associated with prenatal telbivudine exposure. Medicine. 2018;97(9).
Schillie, S, Vellozzi, C, Reingold, A, Harris, A, Haber, P, Ward, J W, et al. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. MMWR. 2018; 67(1): 1-31.
Dunkelberg J, Berkley E, Thiel K, Leslie K. Hepatitis B and C in pregnancy: a review and recommendations for care. Journal of perinatology : official journal of the California Perinatal Association. 2014;34(12):882-891.
OMS: Organización Mundial de la Salud. [Sede Web]. Ginebra: OMS; 2002 [ 30 de septiembre de 2018]. Disponible en: http://www.who.int/es/
Le STT, Sahhar L, Spring S, Sievert W, Dev AT. Antenatal maternal hepatitis B care is a predictor of timely perinatal administration of hepatitis B immunoglobulin. Intern Med J.2017; 47 (8): 915-922.
Tseng TC, Kao JH. Elimination of Hepatitis B: Is It a Mission Possible? BMC Med. 2017; 15 (1): 53.
Calvin P, Zhongping D, Erhei D, Shuqin Z, Guorong H., Yuming W, et al. Tenofovir to prevent Hepatitis B transmission in mothers with high viral load. New England Journal of Medicine. 2016; 374 (24):2324-2334.
Han Z, Yin Y, Zhang Y, Ehrhardt S, Thio C L, Nelson, K, et al. Knowledge of and attitudes towards hepatitis B and its transmission from mother to child among pregnant women in Guangdong Province, China. PLoS One. 2017; 12(6).
Swamy GK, Heine RP. Vaccinations for pregnant women. Obstet Gynecol. 2015; 125 (1): 212- 226.
Komatsu H. Hepatitis B virus: Where do we stand and what is the next step for eradication? World J Gastroenterol. 2014; 20 (27): 8998-9016.
Malgorzata P, Malgorzata SP. Recommendations for the management of prevention of vertical HBV and HCV infection. Epidemiol. 2016; 70:33-34.
Wolfram HG. Reduction of infectivity in chronic Hepatitis B virus carriers among healthcare providers and pregnant women by antiviral therapy. Intervirology. 2014; 57 (3-4):202-11.
Ayçe E, Ekan C, Emine P, Medine CC, Ayçegül ÇÇ,Figen KÇ. Evaluation of the Results of Antiviral Therapy in Pregnant Women with Chronic Hepatitis B. Viral Hepatitis Journal. 2014; 20 (1): 23-27.
Jourdain G, Ngo-Giang-Huong N, Cressey T, Hua L, Harrison L, Tierney C, et al.Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen. BMC Infect Dis. 2016; 16: 393.
Sainato RJ, Simmons EG, Muench DF, Burnett MW, Braun L. Management of infants born to women infected with hepatitis B in the military healthcare system. BMC Res Notes. 2013; 6: 338
Brown RS, McMahon BJ, Lok A, Wong J, Ahmed A, Mouchli M, et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis. Hepatology. 2016; 63(1): 319-333.
Chen ZX, Gu GF, Bian ZL, Cai WH, Shen Y, Hao YL, et al.Clinical course and perinatal transmission of chronic hepatitis B during pregnancy: A real-world prospective cohort study. J Infect. 2017; 75 (2): 146-154.
Sun W, Zhao S, Ma L, Hao A, Zhao B, Zhou L, et al. Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission. BMC Gastroenterol. 2017; 17: 51.
Tsai P-JS, Chang A, Yamada S, Tsai N, Bartholoew ML. Use of Tenofovir Disoproxil Fumarate in Highly Viremic, Hepatitis B Mono-Infected Pregnant Women. Dig Dis Sci. 2014; 59 (11): 2797-803.
Burman BE, Jhaveri MA, Kowdley KV. Third-trimester tenofovir to prevent mother-to-child hepatitis B virus transmission. Indian J Med Res. 2017; 146 (1): 1-4.
Yang M, Qin Q, Fang Q, Jiang L, Nie S. Cesarean section to prevent mother-to-child transmission of hepatitis B virus in China: A meta-analysis. BMC Pregnancy Childbirth. 2017; 17 (1): 303.
Komatsu H.Hepatitis B virus: Where do we stand and what is the next step for eradication? World J Gastroenterol. 2014; 20 (27): 8998-9016.
Gonçalves IC, Gonçalves M. Conhecimentos, atitudes e práticas de enfermeiros e médicos sobre a transmissão vertical da hepatite B. Rev Latino- Am Enfermagem. 2013; 21 (5): 1030-1038.
Downloads
Published
How to Cite
Issue
Section
License
En caso de que el artículo sea publicado, los autores aceptan transferir todos los derechos del trabajo presentado, incluidos los derechos de autor y aquellos relativos a la transmisión electrónica, exclusivamente a CODEM, de manera universal, en todos los idiomas, una vez que el trabajo haya sido aceptado para su publicación dentro de la revista electrónica CONOCIMIENTO ENFERMERO.
El autor podrá hacer copias ilimitadas del trabajo para uso docente, reutilizarlo en su totalidad o parcialmente en un libro escrito por el autor o hacer copias para su distribución en la institución en la que trabaja. CODEM hará mención al nombre del autor en las publicaciones que se realicen del trabajo.
